The Covid epidemic is on the rise again in France

The Covid-19 epidemic, which experienced a brief lull in France after a wave in early autumn, is starting up again, detailed this Friday, November 25 the public health agency, in an already tense context. between bronchiolitis and the onset of influenza.

Last week was marked by a “traffic recovery” of the coronavirus and an increase in hospitalizations, summarized Public Health France, in its weekly report on the epidemic.

“Only come to the pediatric emergency room as a last resort! »

It is currently difficult to obtain precise details of the number of cases in France, due to a social movement by biology laboratories. But the data transmitted by pharmacies clearly show a resumption of cases.

Increase in hospitalizations

This marks the end of a brief lull in the epidemic in recent weeks. The latest wave had hit the country at the end of the summer, in a context favored by the start of the school year.

“We cannot be content with post-epidemic strategies”

The current rebound is already reflected in a “upward recovery in new hospitalizations and critical care admissions”after “four weeks down”, underlines Public Health France. Last week, 4,210 people were hospitalized with a diagnosis of Covid, an increase of 6%.

Covid: should we offer a fourth dose to everyone?

If the total number of hospitalized patients (less than 19,000) remains significantly below the highest levels seen this year, this recovery risks testing an already very difficult health system.

Arrival of winter epidemics

The bronchiolitis epidemic, which mainly affects babies, has been on an unprecedented scale for ten years. And that of seasonal flu, although still undeclared, is coming earlier than usual and raises fears of the impact of a “triple epidemic”.

In this context, while recalling the importance of barrier gestures such as wearing a mask in closed and very busy places, Public Health France encourages the French to update their anti-Covid vaccination. This provides, since the beginning of October, a booster dose for people at risk, which include in particular all those over 60 years of age.

Among 60-79 year olds, only 31.2% are considered protected by vaccination (vaccination less than 6 months old); among those aged 80 and over, 12% (vaccination less than 3 months old), according to data from the health agency as of November 21. As for vaccines adapted to the Omicron variant, 6.1% of 60-79 year olds and 7.9% of 80 year olds and over received a booster with this type of serum.

Leave a Comment